Vurdon-SR

Take the capsule whole with a glass of water, preferably after food to minimize gastrointestinal upset. Do not crush or chew.

Diclofenac inhibits cyclooxygenase (COX-1 and COX-2) enzymes, which are involved in prostaglandin synthesis. Prostaglandins are mediators of pain, inflammation, and fever. By reducing prostaglandin production, Diclofenac exerts its analgesic, anti-inflammatory, and antipyretic effects.

• Known hypersensitivity to diclofenac or other NSAIDs
• Active gastrointestinal ulceration or bleeding
• Severe heart failure
• Severe renal impairment
• Severe hepatic impairment
• Third trimester of pregnancy
• History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs

Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

Symptoms may include lethargy, drowsiness, nausea, vomiting, epigastric pain, GI bleeding. Management is supportive and symptomatic; gastric lavage or activated charcoal may be considered within an hour of ingestion. There is no specific antidote.

Not recommended during the third trimester of pregnancy due to potential fetal harm (premature closure of ductus arteriosus). Use during the first and second trimesters only if clearly needed and the potential benefit outweighs the risk. Small amounts are excreted in breast milk; use with caution or consider alternatives during lactation.

• Known hypersensitivity to diclofenac or other NSAIDs
• Active gastrointestinal ulceration or bleeding
• Severe heart failure
• Severe renal impairment
• Severe hepatic impairment
• Third trimester of pregnancy
• History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs

Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

Symptoms may include lethargy, drowsiness, nausea, vomiting, epigastric pain, GI bleeding. Management is supportive and symptomatic; gastric lavage or activated charcoal may be considered within an hour of ingestion. There is no specific antidote.

Not recommended during the third trimester of pregnancy due to potential fetal harm (premature closure of ductus arteriosus). Use during the first and second trimesters only if clearly needed and the potential benefit outweighs the risk. Small amounts are excreted in breast milk; use with caution or consider alternatives during lactation.